Literature DB >> 19615300

Controversial results with use of probiotics in critical illness: contradictory findings from large multicenter trial.

Jeremy R Stapleton1, Stephen A McClave.   

Abstract

Year:  2009        PMID： 19615300     DOI： 10.1007/s11894-009-0052-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  12 in total

1.  Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.

Authors:  Prashant K Jain; Clare E McNaught; Alexander D G Anderson; John MacFie; Charles J Mitchell
Journal:  Clin Nutr       Date:  2004-08       Impact factor: 7.324

2.  Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial.

Authors:  Katerina Kotzampassi; Evagellos J Giamarellos-Bourboulis; Antonios Voudouris; Pantelis Kazamias; Efthimios Eleftheriadis
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

3.  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Reinhold A Schiller; Jan M Langrehr; Sven Jonas; Stig Bengmark; Peter Neuhaus
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

4.  Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients.

Authors:  Alenka Spindler-Vesel; Stig Bengmark; Irena Vovk; Ognjen Cerovic; Lidija Kompan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Mar-Apr       Impact factor: 4.016

5.  Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality.

Authors:  B J Ammori; P C Leeder; R F King; G R Barclay; I G Martin; M Larvin; M J McMahon
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

6.  Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Martina Mogl; Jan M Langrehr; Natascha C Nüssler; Stig Bengmark; Peter Neuhaus
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

7.  Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial.

Authors:  Travis C B Honeycutt; Mohamed El Khashab; Richard M Wardrop; Kenya McNeal-Trice; Andrea L B Honeycutt; Claudia G Christy; Kshitij Mistry; Bradford D Harris; Jon N Meliones; Keith C Kocis
Journal:  Pediatr Crit Care Med       Date:  2007-09       Impact factor: 3.624

8.  Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study.

Authors:  Attila Oláh; Tibor Belágyi; László Pótó; László Romics; Stig Bengmark
Journal:  Hepatogastroenterology       Date:  2007-03

9.  Comment on: probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen A McClave; Daren K Heyland; Paul E Wischmeyer
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-05-05       Impact factor: 4.016

10.  Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis.

Authors:  A Oláh; T Belágyi; A Issekutz; M E Gamal; S Bengmark
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.